High-dose chemotherapy followed by autologous stem cell transplant ineffective for patients with mantle cell lymphoma

  • Post author:
  • Post category:uncategorized

Late-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant (ASCT) for patients with mantle cell lymphoma (MCL) in remission following their initial treatment.